JP2007534725A5 - - Google Patents

Download PDF

Info

Publication number
JP2007534725A5
JP2007534725A5 JP2007510038A JP2007510038A JP2007534725A5 JP 2007534725 A5 JP2007534725 A5 JP 2007534725A5 JP 2007510038 A JP2007510038 A JP 2007510038A JP 2007510038 A JP2007510038 A JP 2007510038A JP 2007534725 A5 JP2007534725 A5 JP 2007534725A5
Authority
JP
Japan
Prior art keywords
group
agent
seq
polypeptide
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007510038A
Other languages
English (en)
Japanese (ja)
Other versions
JP5128273B2 (ja
JP2007534725A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/051914 external-priority patent/WO2005103716A2/en
Publication of JP2007534725A publication Critical patent/JP2007534725A/ja
Publication of JP2007534725A5 publication Critical patent/JP2007534725A5/ja
Application granted granted Critical
Publication of JP5128273B2 publication Critical patent/JP5128273B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007510038A 2004-04-27 2005-04-27 未分化哺乳動物細胞の分化を骨芽細胞へと誘導するための方法、作用物質、及び化合物スクリーニングアッセイ Expired - Fee Related JP5128273B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EPPCT/EP2004/004522 2004-04-27
EP2004004522 2004-04-27
PCT/EP2005/051914 WO2005103716A2 (en) 2004-04-27 2005-04-27 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts

Publications (3)

Publication Number Publication Date
JP2007534725A JP2007534725A (ja) 2007-11-29
JP2007534725A5 true JP2007534725A5 (https=) 2008-06-05
JP5128273B2 JP5128273B2 (ja) 2013-01-23

Family

ID=34981963

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007510038A Expired - Fee Related JP5128273B2 (ja) 2004-04-27 2005-04-27 未分化哺乳動物細胞の分化を骨芽細胞へと誘導するための方法、作用物質、及び化合物スクリーニングアッセイ

Country Status (7)

Country Link
US (3) US7615626B2 (https=)
EP (3) EP2214018B1 (https=)
JP (1) JP5128273B2 (https=)
CA (1) CA2562833A1 (https=)
ES (1) ES2427177T3 (https=)
MX (1) MXPA06012162A (https=)
WO (1) WO2005103716A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080193500A1 (en) * 2007-02-14 2008-08-14 Mckay William F Effect of LMP-1 overexpression on large and small proteoglycans of the disc
WO2008109369A2 (en) * 2007-03-02 2008-09-12 Mdrna, Inc. Nucleic acid compounds for inhibiting tnf gene expression and uses thereof
WO2008155397A2 (en) * 2007-06-20 2008-12-24 Galapagos N.V. Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases
EP2170374A2 (en) * 2007-07-03 2010-04-07 Andreas Reichert Method for treating diseases related to mitochondrial dysfunction
US8759535B2 (en) 2010-02-18 2014-06-24 High Point Pharmaceuticals, Llc Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
DK2536285T3 (en) 2010-02-18 2018-07-16 Vtv Therapeutics Llc Substituted fused imidazole derivatives, pharmaceutical compositions and methods for their use
TWI622402B (zh) 2010-02-24 2018-05-01 免疫遺傳股份有限公司 葉酸受體１抗體類和免疫共軛物類及彼等之用途
BR112013025415B1 (pt) 2011-04-01 2021-03-16 Immunogen, Inc uso de um imunoconjugado antirreceptor de folato 1 (folr1)
US9200073B2 (en) 2012-08-31 2015-12-01 Immunogen, Inc. Diagnostic assays and kits for detection of folate receptor 1
WO2014129550A1 (ja) * 2013-02-21 2014-08-28 国立大学法人熊本大学 骨分化誘導方法及び骨化促進・抑制分子のスクリーニング方法
JP6247472B2 (ja) * 2013-08-06 2017-12-13 日本メナード化粧品株式会社 幹細胞の未分化状態維持剤及び増殖促進剤
CN113150145B (zh) 2013-08-30 2025-02-14 伊缪诺金公司 用于检测叶酸受体1的抗体和测定
JP6411778B2 (ja) * 2014-06-06 2018-10-24 日本メナード化粧品株式会社 幹細胞の未分化状態維持剤及び増殖促進剤
CN116440279B (zh) 2015-09-17 2026-02-24 伊缪诺金公司 包含抗folr1免疫缀合物的治疗组合
JP6615589B2 (ja) * 2015-11-13 2019-12-04 日本メナード化粧品株式会社 幹細胞の未分化状態維持剤及び増殖促進剤
KR20190123256A (ko) * 2016-07-29 2019-10-31 로저 엘. 카스파 액취증 치료 방법
US11993590B2 (en) 2016-12-04 2024-05-28 712 North Inc. Pyranone compounds useful to modulate OMA1 protease
EP3548039B1 (en) 2016-12-04 2023-07-19 Alavi Khorassani Moghadam, Marcel Victor Ribavirin for use in the treatment of a mitochondrial disease
WO2018138709A1 (en) * 2017-01-30 2018-08-02 National Research Council Of Canada Blood-brain barrier transmigrating compounds and uses thereof
WO2020117886A1 (en) * 2018-12-07 2020-06-11 Vtv Therapeutics Llc Methods of inhibiting osteoclastogenesis and osteoclast activity
US20220267781A1 (en) * 2019-07-26 2022-08-25 Ludwig Institute For Cancer Research Ltd Immune cells with enhanced cytotoxicity and methods of use thereof

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US5354844A (en) 1989-03-16 1994-10-11 Boehringer Ingelheim International Gmbh Protein-polycation conjugates
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5693622A (en) 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
JPH04365487A (ja) * 1990-04-11 1992-12-17 Consortium Elektrochem Ind Gmbh 組換ｄｎａ−構造体、組換ベクター、トランスゲン動物の乳からの蛋白質の取得法、トランスゲン動物の製法及びトランスゲン動物の乳
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
EP0786522A2 (en) 1992-07-17 1997-07-30 Ribozyme Pharmaceuticals, Inc. Enzymatic RNA molecules for treatment of stenotic conditions
FR2714830B1 (fr) 1994-01-10 1996-03-22 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
FR2715847B1 (fr) 1994-02-08 1996-04-12 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
FR2727679B1 (fr) 1994-12-05 1997-01-03 Rhone Poulenc Rorer Sa Nouveaux agents de transfection et leurs applications pharmaceutiques
FR2730637B1 (fr) 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
JPH11335398A (ja) * 1998-05-22 1999-12-07 Hoechst Marion Roussel Kk 新規な骨誘導活性を有する単量体蛋白質およびそれらからなる軟骨・骨疾患の予防および治療薬
US20020192209A1 (en) * 1997-09-17 2002-12-19 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
US6056559A (en) * 1997-10-01 2000-05-02 Berg Technology, Inc. Punched sheet coax header
US6506559B1 (en) * 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
EP0967284A1 (en) * 1998-05-28 1999-12-29 Pfizer Limited Phosphodiesterases
AU2400401A (en) * 1999-12-22 2001-07-03 Tanabe Seiyaku Co., Ltd. Novel phosphodiesterases and genes thereof
US20030108926A1 (en) * 2000-03-15 2003-06-12 Eos Biotechnology, Inc. Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
EP1211313A3 (en) * 2000-11-01 2003-04-23 Pfizer Limited Modulation of PDE11A activity
US20060121550A1 (en) * 2000-11-01 2006-06-08 Burslem Martyn F Modulation of PDE11A activity
GB0204227D0 (en) * 2002-02-22 2002-04-10 Pfizer Ltd Modulation of pde11a activity
US6828473B2 (en) * 2000-11-01 2004-12-07 Pfizer Inc. Modulation of PDE11A activity
US20030104410A1 (en) * 2001-03-16 2003-06-05 Affymetrix, Inc. Human microarray
WO2002092000A2 (en) * 2001-05-11 2002-11-21 Genome Therapeutics Corporation Hbm variants that modulate bone mass and lipid levels
AU2002330714A1 (en) * 2001-05-30 2003-01-02 Biomedical Center In silico screening for phenotype-associated expressed sequences
CA2456199A1 (en) * 2001-08-03 2003-02-13 Gene Logic, Inc. Gene associated with bone disorders
US20030198627A1 (en) 2001-09-01 2003-10-23 Gert-Jan Arts siRNA knockout assay method and constructs
WO2003025176A2 (fr) * 2001-09-17 2003-03-27 Molecular Engines Laboratories Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments
EP1546727A2 (en) * 2002-09-24 2005-06-29 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a)
AU2003295600A1 (en) * 2002-11-14 2004-06-15 Dharmacon, Inc. Functional and hyperfunctional sirna
WO2004070062A2 (en) * 2003-02-04 2004-08-19 Wyeth Compositions and methods for diagnosing and treating cancers
WO2004094636A1 (en) 2003-04-24 2004-11-04 Galapagos Genomics N.V. Effective sirna knock-down constructs
US20060216286A1 (en) * 2003-04-25 2006-09-28 Yasuaki Ito Novel screening method
WO2004099782A2 (en) * 2003-05-05 2004-11-18 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor gpr39 (gpr39)
AU2005224614A1 (en) * 2004-03-12 2005-09-29 Exelixis, Inc. PDES as modifiers of the IGFR pathway and methods of use

Similar Documents

Publication Publication Date Title
JP2007534725A5 (https=)
JP2008516593A5 (https=)
AU2023226698B2 (en) Oligonucleotide probes and uses thereof
AU2023237051B2 (en) Oligonucleotide probes and uses thereof
JP2008503712A5 (https=)
US8883425B2 (en) Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
JP6437467B2 (ja) 線維化疾患治療において有用な分子標的及び化合物、並びにこれらの同定方法
US20160003808A1 (en) Molecular targets and compounds, and methods to identify the same, useful in the treatment of diseases associated with epithelial mesenchymal transition
ES2679798T3 (es) Método para proporcionar linfocitos T específicos de tumor
JP2010538244A (ja) 骨及び関節の変性疾患の治療に有用な分子標的及び化合物並びにその同定方法
KR102534098B1 (ko) 항암제 내성 진단 또는 치료용 조성물
EP2868747B1 (en) Aptamer for periostin and anti-cancer composition including same
JP2008502355A5 (https=)
JP6895175B2 (ja) エクソソーム分泌阻害剤
EP2210112B1 (en) Diagnostic methods for hiv infection
WO2005121778B1 (en) Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases
JP2007533989A5 (https=)
JP6200929B2 (ja) 変形性関節症の治療のための方法及び手段
US9952202B2 (en) Methods of identifying compounds for the treatment of fibrosis by using S1PR5
CN119301256A (zh) 外囊泡融合蛋白及其应用
WO2006063462A1 (en) Polynucleotides and polypeptide sequences involved in the process of bone remodeling
US20260117226A1 (en) Long non-coding rnas as target for treating fibrosis and cancer
HK40007814A (en) Oligonucleotide probes and uses thereof
CN102094042A (zh) 一种znf300基因重组载体及应用